Initially, the gastric phenotype of Runx3-knockout mice and the cause-and-effect relationship between loss of RUNX3 and human gastric cancer development suggested that RUNX3 acts as a tumor suppressor [2]. This evidence concerns the gene RUNX3 and gastric cancer.